From the Departments of Human Nutrition (LATM, AJH, RMJ, and JM) and Medicine (JM), the Riddet Institute (LATM, AJH, RMJ, and JM), and the Edgar National Centre for Diabetes and Obesity Research (LATM and JM), University of Otago, Dunedin, New Zealand.
Am J Clin Nutr. 2014 Jul;100(1):65-79. doi: 10.3945/ajcn.113.081521. Epub 2014 May 7.
Dietary sugars have been suggested as a cause of obesity, several chronic diseases, and a range of cardiometabolic risk factors, but there is no convincing evidence of a causal relation between sugars and risk factors other than body weight.
We conducted a systematic review and meta-analysis of randomized controlled trials that examined effects of the modification of dietary free sugars on blood pressure and lipids.
Systematic searches were conducted in OVID Medline, Embase, Scopus, Cumulative Index to Nursing and Allied Health Literature, and Web of Science databases (to August 2013) to identify studies that reported intakes of free sugars and at least one lipid or blood pressure outcome. The minimum trial duration was 2 wk. We pooled data by using inverse-variance methods with random-effects models.
A total of 39 of 11,517 trials identified were included; 37 trials reported lipid outcomes, and 12 trials reported blood pressure outcomes. Higher compared with lower sugar intakes significantly raised triglyceride concentrations [mean difference (MD): 0.11 mmol/L; 95% CI: 0.07, 0.15 mmol/L; P < 0.0001], total cholesterol (MD: 0.16 mmol/L; 95% CI: 0.10, 0.24 mmol/L; P < 0.0001), low-density lipoprotein cholesterol (0.12 mmol/L; 95% CI: 0.05, 0.19 mmol/L; P = 0.0001), and high-density lipoprotein cholesterol (MD: 0.02 mmol/L; 95% CI: 0.00, 0.03 mmol/L; P = 0.03). Subgroup analyses showed the most marked relation between sugar intakes and lipids in studies in which efforts were made to ensure an energy balance and when no difference in weight change was reported. Potential explanatory factors, including a weight change, in most instances explained <15% of the heterogeneity between studies (I(2) = 36-75%). The effect of sugar intake on blood pressure was greatest in trials ≥8 wk in duration [MD: 6.9 mm Hg (95% CI: 3.4, 10.3 mm Hg; P < 0.001) for systolic blood pressure and 5.6 mm Hg (95% CI: 2.5, 8.8 mm Hg; P = 0.0005) for diastolic blood pressure].
Dietary sugars influence blood pressure and serum lipids. The relation is independent of effects of sugars on body weight. Protocols for this review were registered separately for effects of sugars on blood pressure and lipids in the PROSPERO International prospective register of systematic reviews as PROSPERO 2012: CRD42012002379 and 2012: CRD42012002437, respectively.
有人提出,膳食糖可能是导致肥胖、一些慢性疾病和一系列心血管代谢危险因素的原因,但目前尚无确凿证据表明糖与体重以外的其他危险因素之间存在因果关系。
我们对随机对照试验进行了系统评价和荟萃分析,以考察饮食中游离糖的改变对血压和血脂的影响。
在 OVID Medline、Embase、Scopus、护理学和联合健康文献累积索引以及 Web of Science 数据库(截至 2013 年 8 月)中进行了系统检索,以确定报告了游离糖摄入量和至少一项血脂或血压结果的研究。试验的最短持续时间为 2 周。我们采用随机效应模型的逆方差方法对数据进行了汇总。
在总共 11517 项试验中,有 39 项符合纳入标准;37 项试验报告了血脂结果,12 项试验报告了血压结果。与较低的糖摄入量相比,较高的糖摄入量显著升高了甘油三酯浓度[平均差值(MD):0.11 mmol/L;95%置信区间(CI):0.07,0.15 mmol/L;P < 0.0001]、总胆固醇(MD:0.16 mmol/L;95% CI:0.10,0.24 mmol/L;P < 0.0001)、低密度脂蛋白胆固醇(0.12 mmol/L;95% CI:0.05,0.19 mmol/L;P = 0.0001)和高密度脂蛋白胆固醇(MD:0.02 mmol/L;95% CI:0.00,0.03 mmol/L;P = 0.03)。亚组分析显示,在努力确保能量平衡且体重变化无差异的研究中,糖摄入量与血脂之间的关系最为显著。在大多数情况下,体重变化等潜在解释因素仅能解释研究间变异的 15%以内(I²=36%-75%)。糖摄入量对血压的影响在持续时间≥8 周的试验中最大[收缩压 MD:6.9 mm Hg(95% CI:3.4,10.3 mm Hg;P < 0.001),舒张压 MD:5.6 mm Hg(95% CI:2.5,8.8 mm Hg;P = 0.0005)]。
膳食糖影响血压和血清脂质。这种关系独立于糖对体重的影响。本综述的方案分别在 PROSPERO 国际前瞻性系统评价注册库中以 PROSPERO 2012:CRD42012002379 和 2012:CRD42012002437 号进行了注册,以评估糖对血压和血脂的影响。